What is BPC-157?
A 15-amino-acid peptide derived from a protein in gastric juice, so it's naturally present in the body.
BPC-157 in the library · Healing & Repair Peptides · Human Trials · What are peptides?
3 registered trials · 0 indexed papers · 14 human / 154 animal studies
From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.
What it is
A 15-amino-acid peptide derived from a protein in gastric juice, so it's naturally present in the body. Regarded as the all-purpose systemic repair signal for gut, tendons and ligaments, vessels, joints, liver, heart and brain.
Mechanism (as described)
- Vessels: new vessel growth via VEGFR2; raises HGF; mobilizes endothelial progenitors; supports eNOS. It balances nitric oxide, raising it when repair needs it and preventing excess.
- Cell migration: activates the FAK–paxillin pathway (cells migrate, multiply and survive at the injury).
- Collagen: upregulates type I/III collagen synthesis and fibroblast and chondrocyte migration (tendon-to-bone repair).
- Barriers: tightens gut and blood-brain barrier junctions (ZO-1, occludin, claudins), keeping LPS out of the blood.
- Inflammation: lowers TNF-α, IL-6, IL-1β and NF-κB.
- Mitochondria: better respiration, less oxidative stress; protects stem cells.
- Brain: crosses the blood-brain barrier, calms microglia, raises BDNF, supports acetylcholine and dopamine.
- Organs: protects against ischemia-reperfusion injury. Cardiac data cited: smaller scars, better ejection fraction.
- GH: raises GH-receptor expression, making tissue more responsive to one's own GH/IGF-1.
- Described as having no tachyphylaxis and no hormone suppression with long-term use.
FDA Compounding Panel (July 2026)
At its July 23-24, 2026 meeting, the FDA Pharmacy Compounding Advisory Committee recommended adding BPC-157 (free base and acetate) to the Section 503A bulks list, for the uses FDA reviewed (ulcerative colitis). FDA's own briefing documents had proposed not adding it.
- The vote is advisory and non-binding. It is not FDA approval, and it does not by itself allow pharmacies to compound BPC-157. FDA would have to finish rulemaking to change the final list (21 CFR 216.23), which included no peptides as of October 2026.
- Reported tally (yes-no-abstain): 8-6-1, as reported in law-firm meeting reports. FDA had not posted official minutes or vote results when checked on October 19, 2026.
- FDA: July 23-24, 2026 PCAC meeting materials (substances under consideration)
- FDA: July 23-24, 2026 PCAC final agenda
- eCFR: 21 CFR 216.23, the final 503A bulks list
Registered human trials (3)
| Trial | Phase | Status | Year | Enrolled |
|---|---|---|---|---|
| Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery | Phase 1 | not yet recruiting | 2027 | 30 |
| BPC 157 for Acute Hamstring Muscle Strain Repair | Phase 2 | recruiting | 2026 | 120 |
| PCO-02 - Safety and Pharmacokinetics Trial | Phase 1 | unknown | 2015 | 42 |
More cited research
- BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase (2026, human observational)
- Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT) (2025, human observational)
- Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study (2025, human observational)
- Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study (2024, human observational)
- Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study (2026, animal)
- Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury (2026, animal)
- Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats (2026, animal)
- Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach (2026, animal)
Conditions researched
- Tendon, ligament, muscle & joint injuries (incl. athletes)
- Gut: IBD (Crohn's, colitis), leaky gut, IBS & ulcers
- Concussion, traumatic brain injury & stroke recovery
- Heart repair: after heart attack, heart failure & enlarged heart
- Atherosclerosis, cardiovascular disease & high blood pressure
- Dementia, Alzheimer's & cognitive decline
- Multiple sclerosis
- Ankylosing spondylitis
- Rheumatoid arthritis
- Lupus (SLE)
- Mold illness (mycotoxin exposure)
- Chronic pain: fibromyalgia & CRPS
- Tinnitus
- Migraine
- Raynaud's
- Lung health, asthma & COPD
- Fatty liver & elevated liver enzymes
- Menstrual cramps (dysmenorrhea)
- Endometriosis
- Female fertility
- Fatigue & low energy (incl. midlife)
- Anti-aging & longevity
- Alpha-gal syndrome
- Autism support
- Candida & persistent bacterial infections
- Cognition, focus & brain performance
- Gout
- Gum disease (periodontal) & oral health
- Hashimoto's (autoimmune thyroid)
- High-demand jobs: military, fire, police, EMT (and combat-sport athletes)
- Insulin resistance, prediabetes & type 2 diabetes
- Kidney protection (CKD, diabetic kidney, lupus kidney)
- Low testosterone (without or alongside TRT)
- Lyme disease & chronic infections
- Menopause & perimenopause
- Osteoarthritis, cartilage loss & avoiding joint replacement
- Pancreatitis (after the acute phase)
- Sexual function & libido (women and men)
- Skin, hair loss, wounds & mast-cell/histamine reactivity
- Sleep apnea (obstructive)
- Rosacea
- EBV and reactivated viruses
- Psoriasis and psoriatic arthritis
- Eczema
- Acne
- POTS and dysautonomia
- Trigeminal neuralgia
- Carpal tunnel
- Hemorrhoids and fissures
- Cellulite
- Bursitis
- Bell's palsy
- Varicose veins
- Recurring UTIs
- Prostate inflammation
- Male fertility and sperm
- Dry and flaky skin
- Lipedema
- Fight-or-flight and nervous system overdrive
- Chronic and systemic inflammation
- Acid reflux and GERD
- Delayed gastric emptying on GLP-1 medicines
- Estrogen dominance
- Fat loss, obesity & body recomposition
- High cholesterol and statins
- High ferritin and iron overload
- Hyperparathyroidism
- Lipomas
- Muscle gain, sarcopenia & building muscle after 40
- Post-surgical inflammation and surgery recovery
- Swollen feet and ankles
- Thick blood and blood clots
Related compounds
- ACTH (Corticotropin)
- GHK-Cu (Copper peptide)
- GHK (Copper-Free)
- L-Carnitine
- Glutathione
- Calcitonin
- Endothelin-1
- Cyanocobalamin (Vitamin B12)
- Insulin (regular human)
- Parathyroid Hormone (PTH 1-84)
FAQ
What is BPC-157?
A 15-amino-acid peptide derived from a protein in gastric juice, so it's naturally present in the body.
How many registered human trials study BPC-157?
The PeptideWhiz trial index lists 3 registered trials for BPC-157, the most recent from 2027.
How much published research exists on BPC-157?
By study type, PeptideWhiz counts 14 human and 154 animal studies on BPC-157.
Which conditions is BPC-157 researched for?
Tendon, ligament, muscle & joint injuries (incl. athletes), Gut: IBD (Crohn's, colitis), leaky gut, IBS & ulcers, Concussion, traumatic brain injury & stroke recovery, Heart repair: after heart attack, heart failure & enlarged heart, Atherosclerosis, cardiovascular disease & high blood pressure, Dementia, Alzheimer's & cognitive decline, Multiple sclerosis, Ankylosing spondylitis, Rheumatoid arthritis, Lupus (SLE), Mold illness (mycotoxin exposure), Chronic pain: fibromyalgia & CRPS, Tinnitus, Migraine, Raynaud's, Lung health, asthma & COPD, Fatty liver & elevated liver enzymes, Menstrual cramps (dysmenorrhea), Endometriosis, Female fertility, Fatigue & low energy (incl. midlife), Anti-aging & longevity, Alpha-gal syndrome, Autism support, Candida & persistent bacterial infections, Cognition, focus & brain performance, Gout, Gum disease (periodontal) & oral health, Hashimoto's (autoimmune thyroid), High-demand jobs: military, fire, police, EMT (and combat-sport athletes), Insulin resistance, prediabetes & type 2 diabetes, Kidney protection (CKD, diabetic kidney, lupus kidney), Low testosterone (without or alongside TRT), Lyme disease & chronic infections, Menopause & perimenopause, Osteoarthritis, cartilage loss & avoiding joint replacement, Pancreatitis (after the acute phase), Sexual function & libido (women and men), Skin, hair loss, wounds & mast-cell/histamine reactivity, Sleep apnea (obstructive), Rosacea, EBV and reactivated viruses, Psoriasis and psoriatic arthritis, Eczema, Acne, POTS and dysautonomia, Trigeminal neuralgia, Carpal tunnel, Hemorrhoids and fissures, Cellulite, Bursitis, Bell's palsy, Varicose veins, Recurring UTIs, Prostate inflammation, Male fertility and sperm, Dry and flaky skin, Lipedema, Fight-or-flight and nervous system overdrive, Chronic and systemic inflammation, Acid reflux and GERD, Delayed gastric emptying on GLP-1 medicines, Estrogen dominance, Fat loss, obesity & body recomposition, High cholesterol and statins, High ferritin and iron overload, Hyperparathyroidism, Lipomas, Muscle gain, sarcopenia & building muscle after 40, Post-surgical inflammation and surgery recovery, Swollen feet and ankles, Thick blood and blood clots.
Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).